October 7, 2022NewsroomNews from the HMI
New York, NY – October 5, 2022 – today announced the publication of a manuscript titled “Novel Prokaryotic System Employing Previously Unknown Nucleic Acid-Based Receptors”
News from the HMI
August 9, 2022NewsroomNews from the HMI
New York, NY – August 9, 2022 – today announced the publication of a manuscript titled “Novel Cell Receptor System of Eukaryotes Formed by Previously Unknown Nucleic Acid-Based Receptors”
December 16, 2021NewsroomNews from the HMI
New York, NY (December 16, 2022) – A New-York city-based Human Microbiology Institute presented “Bacterial DNA promotes tau and beta-amyloid aggregation and is suggested as a novel therapeutic target for Alzheimer’s disease” at the Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases.
October 20, 2021NewsroomNews from the HMI
New York, NY (October 20, 2022) – Human Microbiology Institute presented “ERADICATING PSEUDOMONAS PERSISTENCE IN ADULT PATIENTS WITH CYSTIC FIBROSIS WITH A NEW ALGORITHM OF ANTIBIOTIC SELECTION” at the CHEST 2021.
June 12, 2021NewsroomNews from the HMI
New York, NY (June 12, 2022) – Human Microbiology Institute presented their recent data “ERADICATING PSEUDOMONAS PERSISTENCE IN ADULT PATIENTS WITH CYSTIC FIBROSIS WITH A NEW ALGORITHM OF ANTIBIOTIC SELECTION” at the 44th European Cystic Fibrosis Conference.
May 2, 2021NewsroomNews from the HMI
Dr. George Tetz, MD, PhD, Human Microbiology Institute, NY, USA, is an invited speaker at Antibiotics Webinar | Antibiotics vs. Phage Therapy 10 May 2021
This webinar is focused on the comparison and interplay between antibiotics and phage therapy. George Tetz, will be giving a talk on the ole pf phages as possible human pathogens. https://www.mdpi.com/journal/antibiotics/events
April 15, 2021NewsroomNews from the HMI
Abstract Title: Bacterial DNA Promotes Tau and Beta-amyloid Aggregation and Is Suggested as a Novel Therapeutic Target for Alzheimer’s Disease
Our abstract was accepted for an iPoster presentation at the #WorldMicrobeForum! Plan to see me online from June 20-24! Visit the website for details: https://bit.ly/3mLJcg1
July 23, 2020NewsroomNews from the HMI
New York, NY – July 22, 2020) – A New-York city-based start-up TGV-Dx was selected a winner in the special COVID-19 edition of the “Make Your Medical Device Pitch for Kids!” competition presented by FDA-sponsored National Capital Consortium for Pediatric Device Innovation. The competition focused on innovations in COVID-19-related pediatric medical devices that will improve children’s health care, with 16 finalists competing in a virtual pitch event for a share of $250,000 in total grant awards. TGV-Dx received a grant award as a result of their winning presentation